H. B. Berntzen

741 total citations
15 papers, 624 citations indexed

About

H. B. Berntzen is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H. B. Berntzen has authored 15 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H. B. Berntzen's work include S100 Proteins and Annexins (7 papers), Immune Response and Inflammation (6 papers) and Cell Adhesion Molecules Research (3 papers). H. B. Berntzen is often cited by papers focused on S100 Proteins and Annexins (7 papers), Immune Response and Inflammation (6 papers) and Cell Adhesion Molecules Research (3 papers). H. B. Berntzen collaborates with scholars based in Norway, United States and United Kingdom. H. B. Berntzen's co-authors include Magne K. Fagerhol, E Munthe, Ümit Ölmez, Johan G. Brun, Graham Hughes, Ricard Cervera, Hans‐Jacob Haga, Munther A. Khamashta, Egil Jellum and Petter Mowinckel and has published in prestigious journals such as Scandinavian Journal of Clinical and Laboratory Investigation, Scandinavian Journal of Immunology and Lupus.

In The Last Decade

H. B. Berntzen

15 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. B. Berntzen Norway 12 489 344 114 96 60 15 624
Jean-Éric Alard France 9 179 0.4× 293 0.9× 82 0.7× 83 0.9× 68 1.1× 11 541
Amanda Rohrbach United States 5 141 0.3× 327 1.0× 49 0.4× 48 0.5× 30 0.5× 5 413
Banu Balcı‐Peynircioğlu Türkiye 16 469 1.0× 306 0.9× 68 0.6× 40 0.4× 27 0.5× 37 606
Cecilie Okkenhaug Norway 13 142 0.3× 273 0.8× 70 0.6× 28 0.3× 56 0.9× 18 599
M Kagami Japan 9 84 0.2× 171 0.5× 100 0.9× 32 0.3× 20 0.3× 28 382
Milton H. Dalbow United States 12 95 0.2× 95 0.3× 24 0.2× 120 1.3× 70 1.2× 23 509
Kristy L. Edgtton Australia 9 91 0.2× 326 0.9× 67 0.6× 116 1.2× 184 3.1× 11 698
Quentin Simon France 10 63 0.1× 335 1.0× 66 0.6× 30 0.3× 38 0.6× 17 514
Madhu S. Bajaj United States 11 140 0.3× 103 0.3× 23 0.2× 102 1.1× 87 1.4× 20 730
Christianna Choulaki Greece 9 190 0.4× 371 1.1× 196 1.7× 30 0.3× 48 0.8× 13 575

Countries citing papers authored by H. B. Berntzen

Since Specialization
Citations

This map shows the geographic impact of H. B. Berntzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. B. Berntzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. B. Berntzen more than expected).

Fields of papers citing papers by H. B. Berntzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. B. Berntzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. B. Berntzen. The network helps show where H. B. Berntzen may publish in the future.

Co-authorship network of co-authors of H. B. Berntzen

This figure shows the co-authorship network connecting the top 25 collaborators of H. B. Berntzen. A scholar is included among the top collaborators of H. B. Berntzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. B. Berntzen. H. B. Berntzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Haga, Hans‐Jacob, Johan G. Brun, H. B. Berntzen, et al.. (1993). Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity. Lupus. 2(1). 47–50. 93 indexed citations
2.
Hetland, Geir, H. B. Berntzen, & Magne K. Fagerhol. (1992). Levels of calprotectin (leukocyte L1 protein) during apheresis. Scandinavian Journal of Clinical and Laboratory Investigation. 52(6). 479–482. 5 indexed citations
3.
Brun, Johan G., et al.. (1992). Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity.. PubMed. 19(6). 859–62. 59 indexed citations
4.
Berntzen, H. B., et al.. (1991). Calprotectin (the LI protein) during surgery in patients with rheumatoid arthritis. Scandinavian Journal of Clinical and Laboratory Investigation. 51(7). 643–650. 11 indexed citations
5.
Ölmez, Ümit, et al.. (1991). C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 20(3). 183–189. 24 indexed citations
6.
Berntzen, H. B., Magne K. Fagerhol, Monika Østensen, Petter Mowinckel, & H. M. Høyeraal. (1991). The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis.. PubMed. 18(1). 133–8. 52 indexed citations
7.
Berntzen, H. B., Ümit Ölmez, Magne K. Fagerhol, & E Munthe. (1991). The Leukocyte Protein L1 in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Osteoarthritis. Scandinavian Journal of Rheumatology. 20(2). 74–82. 95 indexed citations
8.
Berntzen, H. B. & Magne K. Fagerhol. (1990). L1, a major granulocyte protein; isolation of high quantities of its subunits. Scandinavian Journal of Clinical and Laboratory Investigation. 50(7). 769–774. 34 indexed citations
9.
Berntzen, H. B. & Magne K. Fagerhol. (1990). L1, a major granulocyte protein; isolation of high quantities of its subunits. Scandinavian Journal of Clinical and Laboratory Investigation. 50(7). 769–774. 8 indexed citations
10.
Berntzen, H. B., E Munthe, & Magne K. Fagerhol. (1989). A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis.. PubMed. 16(11). 1416–20. 67 indexed citations
11.
Andersson, Kristin B., Knut Sletten, H. B. Berntzen, et al.. (1988). The Leucocyte L1 Protein: Identity with the Cystic Fibrosis Antigen and the Calcium‐Binding MRP‐8 and MRP‐14 Macrophage Components. Scandinavian Journal of Immunology. 28(2). 241–245. 93 indexed citations
12.
Berntzen, H. B., et al.. (1988). L1, a major granulocyte protein: Antigenic properties of its subunits. Scandinavian Journal of Clinical and Laboratory Investigation. 48(7). 647–652. 19 indexed citations
13.
Berntzen, H. B. & Magne K. Fagerhol. (1988). L1, a major granulocyte protein: Antigenic properties of its subunits. Scandinavian Journal of Clinical and Laboratory Investigation. 48(7). 647–652. 27 indexed citations
14.
Berntzen, H. B., E Munthe, & Magne K. Fagerhol. (1988). The Major Leukocyte Protein L1 as an Indicator of Inflammatory Joint Disease. Scandinavian Journal of Rheumatology. 17(sup76). 251–256. 33 indexed citations
15.
Berntzen, H. B., Karen Willard‐Gallo, E Munthe, & Egil Jellum. (1986). Analysis of cellular and membrane extracts of human leukocytes from rheumatoid arthritis patients using two-dimensional electrophoresis.. PubMed. 184. 77–83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026